Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats. (Q49091555)

18 February 2018

title

Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats. (English)

1 reference

18 February 2018

0 references

1 reference

E Meller

1

1 reference

18 February 2018

publication date

1 January 1982

1 reference

18 February 2018

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 February 2018

volume

76

1 reference

18 February 2018

issue

3

1 reference

18 February 2018

page(s)

222-227

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00432549

exact match

0 references

cites work

Molindone: an indole derivative with antipsychotic activity.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00432549

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

21 January 2018

1 reference

12 December 2020

Physiological significance of dopamine autoreceptors as studied following their selective blockade by molindone

1 reference

12 December 2020

Ethopropazine and benztropine in neuroleptic-induced parkinsonism

1 reference

12 December 2020

A critical evaluation of molindone (Moban): a new indole derivative neuroleptic.

1 reference

12 December 2020

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions

1 reference

12 December 2020

Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

1 reference

12 December 2020

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

1 reference

12 December 2020

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

1 reference

12 December 2020

Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

Antipsychotic drugs: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

1 reference

12 December 2020

Minireview A systematic study of the pharmacological activities of dopamine antagonists

1 reference

12 December 2020

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

1 reference

12 December 2020

On the coexistence of parkinsonism and tardive dyskinesia

1 reference

12 December 2020

Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors

1 reference

12 December 2020

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 reference

12 December 2020

The substituted benzamides - a novel class of dopamine antagonists

1 reference

12 December 2020

Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and α-methyl-p-tyrosine

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

1 reference

12 December 2020

3H-spiroperidol labels dopamine receptors in pituitary and brain

1 reference

12 December 2020

Tardive dyskinesia oral facial dyskinesia with moban

1 reference

12 December 2020

Coexisting tardive dyskinesia and parkinsonism: a case report

1 reference

12 December 2020

Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase

1 reference

12 December 2020

Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine

1 reference

12 December 2020

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

1 reference

12 December 2020

Tardive dyskinesia: review and update

1 reference

12 December 2020

Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics

1 reference

12 December 2020

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine

1 reference

12 December 2020

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

1 reference

12 December 2020

Clozapine--a new antipsychotic agent.

1 reference

12 December 2020

Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone

1 reference

12 December 2020

Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum

1 reference

12 December 2020

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

1 reference

12 December 2020

Brain dopamine receptors

1 reference

12 December 2020

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

12 December 2020

Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes

1 reference

12 December 2020

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00432549

1 reference

18 February 2018

Dimensions Publication ID

0 references

1 reference

18 February 2018